Leading company in industrial biotechnology of rare medicinal plants. Grand Prix Européen de la Qualité, Geneva, Switzerland, 2012, in the nomination “Leader in the Application of Innovations in Biotechnology”.
Production is certified according to international quality standards ISO 9001:2015 and ISO 22000:2005. Manufacturing are located in Kotka (Finland) and St. Petersburg (Russia).
BioPharmos Group research center has been working on a project to create a breakthrough peptide painkiller Anodynal®, a synthetic analogue of the salmon calcitonin molecule fragment.